Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + AT Income Tax - 2017 (1) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2017 (1) TMI 510 - AT - Income Tax


Issues Involved:
1. Disallowance of commission payments amounting to ?67,77,001/-.
2. Verification and restriction of commission payment rate to 3%.

Detailed Analysis:

1. Disallowance of Commission Payments:
The case revolves around the disallowance of commission payments amounting to ?67,77,001/- made by the assessee, a pharmaceutical company, to 13 parties. The Assessing Officer (AO) disallowed these payments despite the assessee providing all relevant details, including confirmations, PAN particulars, TDS deductions, and agreements. The AO's primary contention was the lack of proof of services rendered by the payees. The CIT(A) partially accepted the assessee's appeal, noting that the AO did not prove the expenditure as non-genuine and failed to gather positive evidence by examining the commission agents. The CIT(A) acknowledged the genuineness of the expenditure but directed the AO to verify the rate of commission and restrict it to 3%.

2. Verification and Restriction of Commission Payment Rate:
The CIT(A) observed that the rate of commission payments ranged from 2% to 24%, which seemed excessively high. The CIT(A) noted that the agreements did not specify the rate of commission and that the assessee failed to produce evidence such as sales details or communications from the commission agents. Consequently, the CIT(A) directed the AO to allow the commission payments after verifying and restricting the rate to 3%. However, the tribunal found no cogent reason for the AO or CIT(A) to adopt a different approach from previous assessments, where such commission expenses were accepted as a routine practice in the pharmaceutical business. The tribunal noted that the assessee had deducted TDS at prescribed rates and provided all necessary confirmations. The tribunal concluded that the CIT(A) erred in restricting the commission payments to 3% without any comparative market rate analysis and directed the AO to allow the entire claim of ?67,77,001/-.

Conclusion:
The tribunal allowed the assessee's appeal, directing the AO to allow the full commission payment claim of ?67,77,001/-. The Revenue's appeal to restore the entire disallowance was dismissed. The judgment emphasized the importance of providing concrete evidence and maintaining consistency with previous assessments.

 

 

 

 

Quick Updates:Latest Updates